(NASDAQ: PRE) Prenetics Global's forecast annual revenue growth rate of 86.42% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 4.96%, and it is also forecast to beat the US market's average forecast revenue growth rate of 59.25%.
Prenetics Global's revenue in 2025 is $50,541,973.On average, 2 Wall Street analysts forecast PRE's revenue for 2025 to be $1,226,926,573, with the lowest PRE revenue forecast at $1,190,483,210, and the highest PRE revenue forecast at $1,275,517,725. On average, 2 Wall Street analysts forecast PRE's revenue for 2026 to be $2,498,046,190, with the lowest PRE revenue forecast at $2,423,861,226, and the highest PRE revenue forecast at $2,597,003,633.
In 2027, PRE is forecast to generate $3,255,262,715 in revenue, with the lowest revenue forecast at $3,158,557,315 and the highest revenue forecast at $3,384,291,563.